Project Grant R21NS134232

Award Date 8/1/23
Completion Date 7/31/25
Dollars Obligated $412K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award in the amount of $193,336 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research by Drexel University to investigate the role of medial deep dorsal glycinergic interneurons in regulating locomotor circuits and improving locomotion following spinal cord injury. The research aims to functionally...
This $234,949 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research at Yale University to investigate the capacity and necessity of intact and lesioned supraspinal raphespinal tract terminals in supporting rehabilitation-induced functional recovery after spinal cord injury. The research will leverage anatomy, spatial...
This Project Grant award for $183,397.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) supports research by Drexel University to optimize epidural stimulation for treating spasticity following spinal cord injury. The research aims to determine an optimal electrode configuration for epidural stimulation to reduce spasticity and hyperreflexia in spinal cord...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $1,006,322 to the University of California, San Diego (UCSD) to conduct research on understanding axon repair mechanisms in the mammalian spinal cord. The key objectives are to: Refine and expand a single-cell RNA sequencing-based "regeneration...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded Drexel University a $405,625 Project Grant (R21NS131962) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The funding will support research to investigate the modular organization of respiratory control and changes in the respiratory system after cervical spinal cord injury (SCI) in freely behaving rats. The project aims to: 1) identify basic respiratory modules and...
This $424,875.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund a comprehensive study of gene transcription patterns in diverse classes of neurons that connect the brain to the spinal cord after spinal cord injury in a mouse model. The research team at Marquette University will use single-cell sequencing technologies to profile...
This Project Grant award under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, administered by the National Institute of Neurological Disorders and Stroke (NINDS), provides $391,250.00 to the University of Louisville's Office of Research & Innovation to conduct research aimed at developing effective therapeutic strategies for spinal cord injury (SCI). The key objectives of the research project are to: 1) evaluate temporal regulation...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports development of a novel screening technology to identify FDA-approved drugs that can promote functional recovery in spinal cord injury (SCI). The $411,136 award to the Texas A&M University System Health Science Center will fund a 3-step screening platform using adult cortical...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $330,000 to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab) to conduct research focused on improving walking function for individuals with spinal cord injury (SCI). The key objectives of this 2-year award are to: 1) examine how the reticulospinal tract, a...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the causal effects of pneumonia on spinal cord injury recovery in mice. The $566,089 award to The Ohio State University will fund three specific aims: 1) identifying circulating, humoral factors and potential bacterial infiltration into the...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $411,941 to Drexel University to conduct research on identifying novel trunk reflex pathways and how they differ after neonatal versus adult spinal cord injury in animal models. The key objectives are to test the hypothesis that the newly discovered contralateral monosynaptic trunk reflex pathways are lost after neonatal spinal cord injury, which may help explain the better recovery of quadrupedal function observed in some animal models compared to adult injury. The 2-year project will use anatomical tracing and electrophysiological testing to examine these trunk reflex pathways and their alterations following different timing of spinal cord injury. The findings could help advance understanding of trunk motor control and recovery after spinal cord injury, potentially leading to new therapeutic approaches.

Generated 7/16/24, 4:10 AM